A “Money Blind” for Research into Maternal-Fetal Medication Risk?
By Kate Greenwood [Cross-posted at Health Reform Watch] A week ago, the Food and Drug Administration announced the results of a review of the medical literature it conducted in response to “recent reports questioning the safety of prescription and over-the-counter (OTC) pain medicines when used during pregnancy.” The literature, FDA determined, is inconclusive. FDA found that…